Rationale The mesocorticolimbic dopamine system undergoes significant reorganization of neuronal connectivity and functional refinement during adolescence. Deleted in colorectal cancer (DCC), a receptor for the guidance cue netrin-1, is involved in this reorganization. Previous studies have shown that adult mice with a heterozygous (het) loss-of-function mutation in DCC exhibit impairments in sensitization and conditioned place preference (CPP) to psychostimulants. However, the commonly abused psychostimulant methamphetamine (METH) has not been assessed, and the role of DCC in drug self-administration remains to be established. Objectives Using dcc het mice and wildtype (WT) littermates, we extended previous findings on dcc haplodeficiency by examining self-administration of METH in adult mice, including cue-induced drug seeking following abstinence. We also examined hyperactivity, sensitization, and CPP to a METHpaired context in adult and adolescent mice.
Introduction
Seeking rewards such as food and sex is essential for survival; however, it can lead to maladaptive behavior when expressed pervasively, manifesting as addiction. Drug addiction is a chronic, relapsing neurological disorder characterized by compulsive drug craving, seeking, and use that persists despite serious adverse consequences (Kalivas and Volkow 2005) . Importantly, there is individual variability between drug users in their susceptibility to the effects of drugs (Kalivas 2005) , and animal studies modeling the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) criteria of addiction also report individual differences in mesocorticolimbic circuitry function (Deroche-Gamonet et al. 2004; Kasanetz et al. 2010 Kasanetz et al. , 2013 . In particular, the mesocorticolimbic dopamine system is wellknown for its importance in the consumption of natural rewards, and it is believed that drug use essentially "highjacks" this system in the path to addiction (Kelley and Berridge 2002) .
The neurobiological mechanisms underlying individual vulnerability to addiction are yet to be fully elucidated. Genetic and environmental events occurring early in life may lead to abnormalities in the development of the mesocorticolimbic dopamine system, sensitizing its function later in life (Flores 2011) . How such early events might result in enduring changes in the function of mesocorticolimbic dopamine circuitry is unknown. One possible mechanism is the alteration of the proteins involved in the organization of dopamine circuitry. Netrin-1 is a secreted guidance cue that attracts or repels growing neuronal processes through two main families of receptors. Deleted in colorectal cancer (DCC) receptor is responsible for the role of attraction (Barallobre et al. 2005) , and it is expressed in dopamine neurons (Manitt et al. 2010; Osborne et al. 2005) . Critically, DCC is found in the brain from embryonic life and into adulthood, potentially enabling reorganization of mesocorticolimbic circuits during and following maturation (Livesey and Hunt 1997; Manitt et al. 2011; Osborne et al. 2005) . Thus, mice deficient in dcc (the gene responsible for the receptor DCC) have provided an opportunity to test the role of netrin-1 receptors in mesocorticolimbic dopamine circuitry and its related behaviors. Mice haploinsufficient for dcc have lower levels of DCC protein throughout the brain (Flores et al. 2005) . Heterozygous dcc mice are used because homozygous knockout mice die at birth (Fazeli et al. 1997) . Furthermore, varying DCC levels rather than deleting the receptor altogether provides a model with greater ethological validity (Srour et al. 2010; Flores 2011) .
Consistent with the potential role of DCC in dopamine-related behaviors, in vivo microdialysis studies in adult dcc het mice have shown not only a reduction in amphetamine-induced dopamine release in the nucleus accumbens (NAc) but also an increase of dopamine concentrations in the medial prefrontal cortex (mPFC) before and after amphetamine exposure (Flores et al. 2005) . These results are interesting in light of previous studies that report repeated stimulant use that can cause a decrease in dopamine signaling in the mPFC (Salo et al. 2009 ) and ultimately increase dopamine outflow into the striatum (Evans et al. 2006; Volkow et al. 2006) , which parallels the development of behavioral sensitization (Ventura et al. 2004) . Indeed, adult dcc het mice exhibit significantly attenuated hyperactivity in response to an initial amphetamine injection as well as attenuated behavioral sensitization when treated repeatedly compared to wildtype (WT) littermates (Flores et al. 2005; Grant et al. 2007; Yetnikoff et al. 2010) . Using the conditioned place preference (CPP) model, Grant et al. (2007) also reported that adult dcc het mice failed to acquire a preference to a context paired with a moderate dose (2.2 mg/kg) of amphetamine while acquiring CPP with a high dose (4.4 mg/kg), whereas WT littermates acquired CPP at both doses. These results show diminished sensitivity to the conditioned rewarding properties of amphetamine in dcc het mice, suggesting a role of DCC in mediating drug-related behaviors.
The present study, therefore, further investigated the role of DCC in behaviors relevant to addiction using a commonly abused psychostimulant methamphetamine (METH). METH is an extremely popular illegal substance of abuse particularly among adolescents, second only to the use of cannabis with an estimated global prevalence of 0.4 % (Marshall and Werb 2010) . METH has similar pharmacokinetic and pharmacodynamic properties to amphetamine (Melega et al. 1995) ; however, while evoked NAc dopamine levels are similar for both amphetamine and METH, amphetamine administration results in larger extracellular levels of dopamine in the mPFC than does METH due to amphetamine's superior ability to block dopamine reuptake and clearance, leading to some differences in behavior caused by the two drugs (Shoblock et al. 2003) . Thus, findings on DCC with amphetamine may be due to its differential ability to block dopamine clearance in mPFC, and the role of DCC may not generalize to other drugs.
We first examined the behavioral phenotype of adult dcc het mice using the intravenous self-administration paradigm followed by post-abstinence cue-induced drug seeking because a role of DCC in drug self-administration has not been previously investigated. While behavioral sensitization has been posited by some as a neurobiological process underlying human addiction (Robinson and Berridge 1993) , recent findings have provided initial evidence that propensity to sensitize or learn a place preference is not correlated with a propensity to reinstate drug seeking (Ahmed and Cador 2005; Brown et al. 2010; Lenoir and Ahmed 2007) . Thus, it is necessary and important to examine the role of DCC in a model of relapse following a period of self-administration, especially considering that relapse subsequent to successful detoxification or protracted abstinence remains high and forms the most challenging aspect and a central hallmark of addiction (McLellan et al. 2000) . We also investigated behavioral sensitization and CPP in adult and adolescent dcc het mice and their WT littermates using METH. Grant et al. (2007) demonstrated that in contrast to adult dcc het mice, juvenile and adolescent dcc het mice showed comparable acute hyperactivity and development of sensitization in response to amphetamine as their WT littermates (Grant et al. 2009; Yetnikoff et al. 2011) . These results suggest that reduced DCC receptors may protect against drug-induced behaviors after, but not before, adolescence. Consistent with this idea, dopaminergic innervation to the mPFC continues to develop into adulthood (Benes et al. 2000; Flores 2011; Kalsbeek et al. 1988; Rosenberg and Lewis 1995) . However, the ability of adolescent dcc het mice to learn CPP remains untested. If it is the case that adolescent dcc het mice display CPP comparable to their WT littermates, it would highlight adolescence as a vulnerable period to drug abuse regardless of DCC levels.
Materials and methods

Animals
Adolescent male dcc het and WT mice bred on a C57Bl/6 background at the University of Queensland were used (the fully backcrossed C57Bl/6 strain was obtained from Prof. Linda Richards (Queensland Brain Institutes)). The original 129sv × C57Bl/6 strain was provided by Dr Marc Tessier-Lavigne (Keino-Masu et al. 1996) . Pups were weaned at postnatal day (P) 21±1 and housed in cages with same sex littermates. Adult mice were P105 (±30) and adolescents P30 (±2) on day 1 of any experiment. For CPP experiments, mice were housed together with littermates on a 12-h light/dark cycle (lights on at 7 a.m.). For the intravenous self-administration experiment, mice were singly housed on a 12-h reverse light/dark cycle (lights on at 7 p.m.). Housing was in standard mouse boxes with access to water and mouse chow ad libitum.
Polymerase chain reaction
Genotypes were unknown during experimentation and validated after completion of each experiment. Mice genotypes were validated using polymerase chain reaction (PCR). DNA from tail samples was extracted using the REDExtract-N-AmpTM Tissue PCR Kit (Sigma). The following forward and reverse primers (Geneworks, Australia) were used: 5′-TCCTCGT GCTTTACGGTATC-3′, 5′-GGCCATTGAGGTTCCTTT-3′, and 5′-AAGACGACCACACGCGAG-3′.
Surgery
In order to allow the mice to intravenously self-administer METH, catheters were implanted into the left jugular vein as described previously (Madsen et al. 2012 ). Mice were anesthetized with isoflurane (1.5 %-2 %) and injected with 0.1 ml of meloxicam (5 mg/kg, intraperitoneally (i.p.)) for pain relief and to prevent inflammation. The catheter was flushed with heparinized saline with antibiotic (90 U/ml heparin, 0.03 mL neomycin sulfate 4 mg/mL) to prevent infections and a small amount of blood drawn back through the line to test the patency of the catheter. Mice were then allowed at least 48 h to fully recover before beginning intravenous-self administration. Catheters were flushed twice daily, immediately prior to each session with 0.02 ml of 10 U heparinized saline with antibiotic and immediately after each session with 0.02 ml of 90 U heparinized saline. At the conclusion of the experiment, catheters were tested for patency with 0.02 ml of a ketamine (15 mg/ml, Sigma). A sign of lost muscle tone within 3 s of ketamine infusion was regarded as intact patency. One WT mouse and one dcc het mouse failed the patency test and were excluded from all analyses.
Operant self-administration The ceiling, backwall, and door of each operant chamber (Med Associates Inc, VT, USA) were made of clear Perspex, while the sidewalls consisted of aluminum channels to hold modular components. The floor was a grid consisting of stainless steel rods set above a catch pan. Two retractable levers were located 20 cm apart on one sidewall. A stimulus light was located immediately above the active lever.
In order to shape the mice with the operant task, mice were first trained to lever press for a 5 μl delivery of a 10 % sucrose solution into a receptacle as described previously (Madsen et al. 2012; Brown et al. 2009) . A drop of vanilla essence was placed below the active lever for the duration of the experiment functioning as a stimulus discriminative cue (S+). Reward delivery also coincided with the illumination of the stimulus light functioning as a conditioned stimulus (CS+). A fixed ratio 1 (FR1) reinforcement schedule was used in which each active lever press resulted in one reward delivery. Following sucrose training, mice underwent jugular vein catheterization surgery as described above.
Methamphetamine intravenous-self administration (IVSA) sessions were 2 h daily on FR1. Depression of the active lever resulted in the intravenous infusion of METH (20 μL) coupled with a light-conditioned stimulus (CS+) above the lever. In order to prevent overdose, there was a 10-s time-out period subsequent to each infusion during which active lever presses resulted in no outcome, and the maximum drug infusions per session was set to 100. Based on previous data from our laboratory (Chesworth et al. 2013) , a "moderate" dose of 3 μg/kg/per infusion was used for the first 6 days followed by a lower dose (1 μg/kg) and a higher dose (10 μg/kg) for 3 days each. FR1 was followed by 1 day of progressive ratio (PR), tested at the final dose (10 μg/kg). The PR schedule consisted of an initial infusion that required a single lever press with each subsequent infusion requiring exponentially more effort (lever presses needed for each subsequent infusion: 1, 3, 9, 13, 16, 18, 20, 22, etc.) . Previous studies suggest that a 2-h session provides reliable information regarding the mouse's motivation to acquire drug (Brown et al. 2009; Soria et al. 2006) . Three WT and three dcc het mice were only tested at the 3-μg/kg dose throughout the experiment. Therefore, the PR and dose-response data analyses excluded these mice.
Following the last IVSA session, mice received forced abstinence for a period of 3 weeks in their home cages, after which cue-induced drug seeking was measured. This was a 1-h session during which the stimulus discriminative odor cue was present (S+), and the CS illuminated with each active lever press (CS+), but no reward was delivered. This allowed for the assessment of drug-seeking behavior without the confounding effect of the drug (Brown et al. 2009; Madsen et al. 2012 ).
Conditioned place preference
The CPP apparatus (Lafayette Instruments, Indiana, USA) consisted of two main conditioning compartments with differences in visual and tactile cues, separated by a "neutral" compartment. The light intensity of the conditioning compartments and central compartment were 80 lx and 380 lx, respectively. In every session, infrared sensors recorded distance traveled (centimeters) and time spent (seconds) in each compartment (Brown et al. 2010) . Each experimental session ran for 30 min. Mice were brought into the experimental room half an hour before each session for acclimatization. On day 1 at 3 p.m. (±30 min), mice were i.p. injected with saline, placed in the central compartment, and given free access to the entire apparatus. This allowed for measurement of their baseline preference before conditioning. Allocation of the METH-paired chamber was random and unbiased. For conditioning on days 2-5, mice were given an injection (i.p.) of saline at 9 a.m. (±30 min) and METH (2 mg/kg or 1 mg/kg) at 3 p.m. (±30 min) and were immediately confined into one of the two conditioning compartments. Injection volume was always 10 ml/kg. For test on day 6, mice were again placed into the central compartment at 3 p.m. (±30 min) and given free access to the entire apparatus, without any injection. Data were recorded using Motor Monitor software (Kinder Scientific, CA, USA).
Statistical analyses
To examine the effect of genotype and dose on METH selfadministration, a mixed-design two-way repeated measures (RM) analysis of variance (ANOVA) was performed on the total number of daily infusions. Comparison of PR breakpoint and cue-induced drug-seeking post-abstinence between genotypes was examined using an independent means two-tailed t test. CPP data were analyzed using a mixed-design two-way RM ANOVA on comparing genotypes and preference for METH-paired context at baseline and at test. Locomotor data were similarly examined using a mixed-design RM ANOVA comparing genotype and locomotor activity in response to METH and saline. A two-way between subjects ANOVA was used to examine the collapsed conditioned hyperactivity data. For significant interactions, Fig. 1 Intravenous self-administration of METH on FR1 schedule. a Number of METH infusions for all doses across days. There were no differences between the genotypes. b Number of active and inactive lever presses averaged across all doses (last 3 days of the initial dose was used to reduce confound from sucrose training). There were no differences between the genotypes. WT and het indicate wildtype (n=9) and heterozygote (n=11), respectively Fig. 2 a Dose-response curve for both genotypes. WT and het indicate wildtype (n=6) and heterozygote (n=8), respectively. WT mice displayed a trend towards a significant quadratic function in response to different doses of METH, which was not observed in dcc het mice. b Progressive ratio schedule of reinforcement for both genotypes (10 μg/kg).
No differences between the genotypes were observed for either breakpoint or the number of infusions. WT (n=6) and het (n=8). c Number of active lever presses during cue-induced drug-seeking test following 3 weeks of abstinence. There were no genotype effects. WT (n=9) and het (n=11) appropriate post hoc t tests were performed. Differences were deemed statistically significant if p<0.05.
Results
Experiment 1: Adult dcc het mice exhibit comparable METH self-administration and seeking after abstinence to WT littermates A two-way mixed-design RM ANOVA of active lever responses during sucrose training showed a significant main effect of day (F(7,144) = 18.3, p<0.05) with no effect of genotype (n=9 WT, n=11 het) or interaction (largest F<1) (data not shown). That is, all mice increased responding for sucrose across days, but there was no effect of genotype.
For METH self-administration, the number of infusions at each dose was analyzed the same way as sucrose. At the initial dose of 3 μg/kg, both genotypes showed similar METH selfadministration as indicated by a main effect of day (F(5,90) = 3.8, p<0.05) but no effect of genotype (F(1,18) = 1.1, p>0.05) or interaction (F<1) (Fig. 1a) . When the dose was lowered to 1 μg/kg, there were neither main effects nor an interaction (Fs<1). When the dose was increased to 10 μg/kg, there were again no significant effects (largest F=1.4, p>0.05). Discrimination between the active and inactive lever was generally above 70 % and never below 60 %, and there were no genotype differences in the number of inactive lever presses at any dose (biggest F=1.2) (Fig. 1b) .
The average number of infusions at each dose was then examined for each genotype to determine whether the ability to dynamically regulate self-administration to changing doses was mediated by DCC. Only the mice that received all three different doses were analyzed. Additionally, the last 3 days of the intermediate (3 μg/kg) dose were analyzed as this corresponded to stable self-administration following acquisition. A two-way mixed-design RM ANOVA revealed no effect of dose (F<1), genotype (F<1), nor overall interaction (F(2,24) = 1.7, p>0.05).
To specifically examine whether mice altered drug intake based on dose, we additionally analyzed by within-subjects quadratic contrast ANOVA using the same RM factor (dose) and between factors (genotype). Interestingly, even with a low sample population, there was a strong trend towards dose × genotype quadratic interaction (F(1,12) = 4.6, p=0.054), suggesting that WT regulated intake of METH when dose was changed whereas dcc het mice did not (Fig. 2a) . Note that doses are plotted in the temporal sequence experienced by the mice.
An independent means two-tailed t test showed that the breakpoint and infusions during PR for WT and dcc het mice were not significantly different (ts<1) (Fig. 2b) . Similar analysis found no effect of genotype on cue-induced drug-seeking post-abstinence (t<1) (Fig. 2c) . Inactive lever presses did not differ for both PR and cue-induced drug-seeking test (biggest t=1.3, data not shown).
Experiment 2: Adult dcc het mice show impaired hyperactivity to METH that persists across multiple injections
We first determined METH-induced hyperactivity by comparing the total distance traveled (i.e., locomotion) during saline and METH sessions using a mixed-design RM ANOVA (n=12 per genotype). On day 1 of the conditioning phase, all adult mice showed METH-induced acute hyperactivity as indicated by the significant main effect of drug (F(1,22) = 137.0, p<0.05). There was no main effect of genotype (F(1,22) = 3.1, p>0.05); however, there was a significant drug×genotype interaction (F(1,22) = 4.4, p<0.05). Post hoc analyses indicated that the acute effect of first exposure to METH was greater in WT than hets (t(22) = 2.1, p<0.05), while saline had no differential effects (t<1) (Fig. 3a) . The significant drug × genotype interaction was still present by conditioning day 4 (F(1,22) = 4.9, p<0.05), with WT displaying a greater response to METH than het mice (t(22) = 2.8, p<0.05), indicating that adult dcc het mice continued to exhibit impaired hyperactivity to METH compared to Fig. 3 Adult locomotor activity (n=12 per genotype). Total distance traveled following injection of saline or METH (2 mg/kg i.p.) a on day 1 and day 4 and b across 4 days. The asterisk indicates a significant difference between WT and het mice following METH injections, p<0.05. The acute effect of first exposure to METH was greater in WT than het mice, and this effect was still present by conditioning day 4. METH-induced hyperactivity increased across days for both genotypes WT (Fig. 3b) . A three-way mixed-design RM ANOVA across all days of METH exposure revealed a significant main effect of drug (F(1,22) = 331.2, p<0.05), no effect of days (F<1), and a significant interaction between drug × days (F(3,66) = 23.9, p<0.05), indicating that METH-induced hyperactivity increased across days. However, there was no significant interaction between genotype, drug, and day (F(3,66) = 1.4, p>0.05) (Fig. 3b) .
Conditioned place preference for the METH-paired chamber was calculated by dividing time spent in that chamber by the combined time spent in saline and METH chambers at test (i.e., CPP score = METH / (METH + saline)). A two-way mixeddesign RM ANOVA revealed a main effect of session (F(1,22) = 14.3, p<0.05). However, there was no main effect of genotype nor an interaction (Fs<1) (Fig. 4a) . This result suggests that the ability to acquire CPP using 2 mg/kg of METH is intact in adult dcc het mice. Hence, we replicated the experiment in a new cohort of mice using a lower conditioning dose of METH (1 mg/kg) because Grant et al. (2007) reported the emergence of a CPP phenotype in adult dcc het mice with moderate but not high dose amphetamine. When 1 mg/kg METH was used, RM ANOVA revealed a trend towards session (F(1,16) = 3.9, p=0.067), but no significant effect of genotype (F<1) nor session × genotype interaction (F(1,16) = 1.8, p=0.2). To confirm whether WT littermates could acquire CPP using 1-mg/kg METH, we performed pairwise t tests across session per genotype (Fig. 4b) . WT displayed a significant increase in the preference score to METH-paired chamber (t(10) = 3.4, p<0.05) whereas het mice did not (t<1).
Experiment 3: Adolescent dcc het mice show impaired hyperactivity to METH that recovers across multiple injections On day 1 of the conditioning phase, adolescents (n=11 per genotype) showed METH-induced acute hyperactivity as indicated by the significant main effect of drug (F(1,20) = 12.7, p<0.05). There was no effect of genotype (F(1,20) = 1.8, p>0.05), but there was a significant drug × genotype interaction (F(1,20) = 7.5, p<0.05). Post hoc tests indicated that the acute effect of first exposure to METH was greater in WT than hets (t(20) = 2.3, p<0.05), while saline had no differential effects (t<1) (Fig. 5a ). Unlike adult mice, this difference was only present on the first day of METH injection; by the second day and onwards, there was no difference in locomotor activity between the two genotypes (biggest F(1,20) = 2.05, p>0.05; see Fig. 5a for the final METH injection on conditioning day 4). Analysis across days revealed a significant main effect of days (F(3,60) = 18.3, p<0.05), drug (F(1,20) = 127.5, p<0.05) and a significant interaction between days × drug (F(3,60) = 38.1, p<0.05), but there was no interaction between days, drug, and genotype (F(3,60) = 1.3, p>0.05), indicating that METH-induced hyperactivity increased across days similarly for both genotypes (Fig. 5b) . Fig. 4 a Conditioned place preference (CPP) to METH (2 mg/kg) increased similarly compared to baseline across genotype in adult mice (n=12 per genotype). The asterisk indicates a significant difference of the test data compared to baseline, p<0.05. b CPP to a low dose of METH (1 mg/kg). Only WT mice displayed an increase in METH-side preference compared to the baseline. WT (n=11) and het (n=7). The asterisk indicates a significant difference of the test data compared to baseline in WT mice, p<0.05
Fig. 5 Adolescent locomotor activity (n=11 per genotype). Total distance traveled following injection of saline or METH (2 mg/kg i.p.) a On day 1 and day four and b across 4 days. The acute effect of first exposure to METH was greater in WT than het mice; however, this effect was limited to day 1. METH-induced hyperactivity increased across days for both genotypes. The asterisk indicates a significant difference between WT and het mice following METH injections on day 1, p<0.05 CPP did not differ between genotypes. Analyses revealed that time spent in the METH paired chamber was greater on test day than on baseline day as indicated by a main effect of session (F(1,20) = 31.27, p<0.05). There was no effect of genotype (F<1) nor an interaction (F(1,20) = 1.3, p>0.05) (Fig. 6a ).
Conditioned hyperactivity
To examine age-related changes in conditioned hyperactivity, speed (centimeter per second) of the mice in the 2 mg/kg METH-paired chamber during test session (drug-free) in experiments 2 and 3 was collapsed and analyzed. There were a main effect of age (F(1,42) = 34.3, p<0.05) and no effect of genotype (F<1) but a significant age × genotype interaction (F(1,42) = 8.0, p<0.05) indicating that WT mice displayed a greater increase in conditioned hyperactivity postadolescence than dcc het mice (Fig. 6b) . Post hoc independent samples t tests indicates that both WT and dcc het adult mice displayed a significantly higher hyperactivity compared to their adolescent counterparts (ps<0.05).
Discussion
The present study extends previous work examining the role of the netrin-1 receptor DCC in addiction-related behaviors. Adult dcc het mice self-administered METH and exhibited comparable cue-induced drug-seeking post-abstinence as WT littermates. There was however a strong trend (p=0.054) towards an interaction of the dose-response function across genotype suggesting that WT mice effectively modulated their number of METH infusions related to dose, whereas dcc het mice did not. At a low dose of METH (1 mg/kg), adult dcc het mice did not develop CPP. At a higher dose of METH (2 mg/kg), both adult and adolescent mice developed comparable METH-induced CPP across genotypes. Furthermore, both adult and adolescent dcc het mice showed impaired acute locomotor hyperactivity to METH. Lastly, there was a developmental dissociation in conditioned hyperactivity to the METH-paired context; WT mice displayed a significant age-associated increase whereas dcc het mice did not.
Self-administration
We show here for the first time that there were no differences between dcc het and WT littermates in lever pressing for sucrose. This is important, as it demonstrates that instrumental learning for a reward was intact in the het mice. The mesocorticolimbic dopamine pathways are responsible for the mediation of natural rewards as well as drugs of abuse (Kelley and Berridge 2002) . Thus, it could plausibly be expected that DCC deficiencies would lead to attenuated sucrose reinforcement. Therefore, the ability of hets to acquire the sucrose-reinforced response clearly shows that they are able to form action-outcome associations.
Also, we show that the dcc receptor is not necessary for METH self-administration, since dcc het mice showed essentially comparable behavior as WT littermates. Based on the previous findings with amphetamine (Grant et al. 2007) , it was expected that het mice would show a rightward shift in the dose response during METH self-administration. Specifically, we hypothesized that dcc het mice would show an attenuated response for the lower dose, with a possible augmented response for the higher dose compared to WT littermates. Although there were no significant differences between the genotypes at any given dose, WT littermates showed clear evidence of titration of METH selfadministration as a function of dose changes, a pattern not observed in dcc het mice. That is, dcc het mice failed to modulate the level of self-administration according to dose and maintained similar levels of responding throughout the experiment. This result suggests that dcc haplodeficiency Fig. 6 a Conditioned place preference to METH (2 mg/kg) increased similarly compared to baseline across genotype in adolescent mice (n=11 per genotype). The asterisk indicates a significant difference of the test data compared to baseline, p<0.05. b Speed (centimeter per second) in the METH-paired chamber on test day as a measure of conditioned hyperactivity. Conditioned hyperactivity was greater in adults (n=12 per genotype) than adolescents (n=11 per genotype), an effect that was greater in wildtypes than heterozygotes. The asterisk indicates a significant difference of the adult speeds compared to adolescent speeds, p<0.05 leads to altered sensitivity to dose changes during METH self-administration and that reduced DCC receptor levels during adulthood may lead to altered drug abuse patterns. Notably, in WT mice, the lowest dose of METH supported the greatest number of actual drug infusions, which declined as dose was subsequently increased. In contrast, het mice showed similar numbers of drug infusions across all three doses. This may suggest that dcc het mice are relatively insensitive to the acute aversive after effects of METH compared to WT mice, or the in vivo half life of METH may be reduced in het compared to WT littermates. A more definitive answer requires assessment over an increased range of doses to generate complete curves for each genotype.
The progressive ratio schedule is believed to be a more sensitive measure of the reinforcing efficacy of the drug, and it is particularly useful following training with a FR regimen (Arnold and Roberts 1997) . In our study, both genotypes showed a similar breakpoint when PR was tested. Additionally, both genotypes showed comparable cue-induced drug seeking following 3 weeks of abstinence. These findings indicate that the motivation to consume methamphetamine and the ability to retrieve cue-drug associations are intact in dcc het mice. Such results contrast with the previously demonstrated importance of DCC in drug-induced sensitization and locomotor hyperactivity, supporting the idea that the mechanisms mediating sensitization are not entirely the same as those of the mediating drug-seeking (Ahmed and Cador 2005; Brown et al. 2010; Lenoir and Ahmed 2007) .
Conditioned place preference and locomotor hyperactivity Consistent to findings on amphetamine-induced CPP that showed a rightward shift in the dose response for heterozygous mice (Grant et al. 2007 ), compared to their WT littermates, dcc het adult mice showed an impairment in exhibiting CPP when the dose of METH was low (1 mg/kg) but displayed a similar preference when the dose of METH was increased (2 mg/kg). CPP for METH in mice has been established using doses ranging from 1-5 mg/kg and (Chen et al. 2003) ; hence, our "higher" dose of METH (2 mg/kg) should be regarded as moderate, and it is noteworthy that adult dcc het mice acquired CPP as well as WT littermates. Furthermore, examination of the locomotor activity shows clear genotype differences at the 2-mg/kg dose of METH, that is, adult hets showed significant attenuation of locomotor activity in response to 2 mg/kg METH throughout the CPP conditioning phase. This attenuation of METH-induced locomotor activity in adult dcc het mice is similar to the previously demonstrated attenuation of amphetamineinduced locomotion (Flores et al. 2005; Grant et al. 2007; Yetnikoff et al. 2010 ) and suggests a parallel role for DCC in both METH and amphetamine-related increase in dopamine release in the striatal complex. These findings highlight that acute drug-induced hyperactivity does not necessarily correlate with the acquisition of CPP, which is consistent with previous findings that showed no relationship between CPP and locomotion in inbred C57BL/6 J and DBA/2 J mice using four different doses of cocaine or morphine (Orsini et al. 2005) . Taken together, the present results show that reduced DCC leads to impaired acute METH-induced hyperactivity but does not lead to overall deficits in learning or memory-Pavlovian conditioning is clearly intact. This is important, as addiction is often conceptualized as a pathological form of learning (Berke and Hyman 2000) . Furthermore, these results confirm our self-administration results that DCC-deficient mice are able to experience the positively reinforcing effects of the drug and learn associations between a cue and a drug.
As with the adult het mice, adolescent het mice showed attenuated METH-induced locomotor hyperactivity. However, unlike adult mice, this effect was only observed during the first conditioning exposure to METH when the mice were drug naive. In response to repeated METH injections, adolescent dcc het and WT mice showed comparable locomotor hyperactivity. This was not the case for the adults where dcc het mice showed attenuated METH-induced locomotor activity on each challenge. This attenuated acute METHinduced hyperactivity displayed by adolescent dcc het mice is consistent with the previous report using amphetamine (Yetnikoff et al. 2013) . In that study, locomotor activity was measured during 90-min sessions and reported an overall trend of reduced acute responding to amphetamine in adolescent dcc het mice compared to WT mice even across repeated injections (Yetnikoff et al. 2013) . In contrast, the present study examined locomotor activity over 30-min sessions capturing the very initial response to METH. Taken together, it appears that locomotor differences between adolescent dcc het and WT mice may emerge at slightly different times depending on the type of psychostimulant injection and the length of time measured.
Conditioned hyperactivity
The ability of the METH-paired chamber to elicit hyperactivity even when a mouse is in a drug-free state is known as conditioned hyperactivity. Although controversial, there seems to be a strong evidence that this effect relies on classic associative learning processes (Rauhut and Bialecki 2011) . While overall, there was a significant increase in conditioned hyperactivity in adult mice than in adolescent mice, this effect was greater in WT compared to dcc het mice. Conditioned hyperactivity relies on both the presence of METHinduced hyperactivity and intact associative learning processes responsible for associating this hyperactivity with its context during conditioning sessions. Given that the dcc het mice in the present study successfully established a CPP to the same extent as WT mice using 2 mg/kg METH, differences in conditioned hyperactivity between genotypes are likely due to differences in METH-induced locomotor hyperactivity; that is, while the ability of METH to induce locomotor hyperactivity increases with the age in WT mice, the ability of METH to induce locomotor hyperactivity in dcc het mice remains unchanged at the moderate dose.
The mPFC, unlike the NAc, is a structure that continues to develop through adolescence and into early adulthood Rosenberg and Lewis 1995) . Indeed, it has been shown that dopamine innervation of mPFC in rats continues until postnatal day 60 (Kalsbeek et al. 2008) . Dopamine in the PFC can ultimately control NAc dopamine levels (Ventura et al. 2004) . Dopamine release in striatal regions such as the NAc is a critical determinant for acute drug-induced hyperactivity, which may explain the difference in METH-induced conditioned hyperactivity between adolescent and adult mice. Interestingly, the dopamine innervation to the mPFC undergoes reorganization during adolescence and exhibits, in adulthood, an increased span of mPFC dopamine terminals as well as increased extracellular levels of dopamine (Mannit et al. 2011 ). Thus, drug-induced dopamine release in the NAc remains low in adult dcc het mice as opposed to their WT littermates suggesting a mechanism by which reduced DCC may actually confer "protection" to the effects of stimulant drugs in adulthood.
The findings from conditioned hyperactivity, exhibited during a drug-free CPP test session, suggest that mice that have developed with lower DCC are relatively protected against certain dopamine-related behavioral alterations through differential dopamine organization in the mPFC during maturation. If vulnerability to addiction does in fact involve DCC-mediated signaling, the differences in conditioned hyperactivity suggest that risk factors would have their greatest impact early in adolescence. While environmental factors during adulthood could act via DCC to reorganize dopamine pathways, reorganization of a more stabilized brain would be relatively more difficult. During adolescence, on the other hand, when the mPFC is maturing and in a labile state, the potential of environmental factors to act via DCC to enhance or impair this stabilization is greatly increased. Thus, risk factors known to be associated with substance dependence would be far more influential during adolescence. Furthermore, the use of psychostimulants during adolescence could alter DCC levels in dopamine neurons, eliminating any existing protection that an individual with previously low levels of DCC may have had (Yetnikoff et al. 2011) . The influence of stimulant drug use in adolescents with previously low levels of DCC is important as DCC heterozygosity has recently been identified among the human population (Srour et al. 2010) . The identification of adolescence as a potentially sensitive time for developing substance dependence should be considered when discussing the use of prescription drugs such as methylphenidate, often prescribed to children with attention deficit hyperactive disorder (Leonard et al. 2004 ).
In conclusion, we have extended the previously demonstrated importance of DCC in amphetamine-and cocaine-induced locomotor hyperactivity using METH. Notably, the effects of dcc haplodeficiency on drug-induced locomotor changes did not correlate with the ability to acquire CPP to a METH-paired context. Despite the previously demonstrated importance of DCC in amphetamine-and cocaine-induced sensitization, DCC was shown to have a limited role in METH selfadministration and cue-conditioned drug seeking. This supports previous findings that the mechanisms mediating sensitization are not entirely the same as those of the mediating relapse (Ahmed and Cador 2005; Brown et al. 2010; Lenoir and Ahmed 2007) . Nevertheless, since there are overlaps in the neurocircuitry of sensitization and relapse-like behaviors (Steketee and Kalivas 2011) , further work is needed to understand this dissociation with greater clarity. Subsequent studies on large cohorts could divide the mice into groups based on whether or not they display addict-like behaviors (e.g., difficulty stopping drug use, high motivation to obtain the drug, continued drug use despite negative consequences). DCC could then be measured in each group to more accurately assess the correlation between DCC and addiction-related behaviors.
